|
|
|
|
|
|
1 | Recruiting | Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis | ||||
Conditions: | Polyarticular Juvenile Idiopathic Arthritis; Juvenile Idiopathic Arthritis; Juvenile Rheumatoid Arthritis; Extended Oligoarthritis Juvenile Idiopathic Arthritis | |||||
Interventions: | Drug: methotrexate; Drug: methotrexate, etanercept, prednisolone | |||||
2 | Recruiting | Study Evaluating Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis | ||||
Conditions: | Ankylosing Spondylitis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Spondylitis, Ankylosing | |||||
Intervention: | Drug: etanercept | |||||
3 | Not yet recruiting | Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia | ||||
Conditions: | Ankylosing Spondylitis; Psoriatic Arthritis; Rheumatoid Arthritis | |||||
Intervention: | ||||||
4 | Recruiting | Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis | ||||
Conditions: | Rheumatoid Arthritis; Arthritis | |||||
Interventions: | Drug: Adalimumab; Drug: Methotrexate | |||||
5 | Recruiting | Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis | ||||
Condition: | Arthritis | |||||
Intervention: | Biological: Quadrivalent HPV vaccine (Gardasil®) | |||||
6 | Recruiting | Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-Bearing Total Knee System | ||||
Conditions: | Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Juvenile Arthritis | |||||
Intervention: | Device: Total knee arthroplasty | |||||
7 | Recruiting | Ankle Joint Replacement Outcomes Study | ||||
Conditions: | Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Septic Arthritis; Prior Ankle Fusion | |||||
Intervention: | Device: ankle joint replacement | |||||
8 | Recruiting | Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults | ||||
Condition: | Juvenile Idiopathic Arthritis | |||||
Intervention: | Biological: Rilonacept | |||||
9 | Recruiting | Remicade® Rheumatology Registry Across Canada (Study P02843) | ||||
Conditions: | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic | |||||
Intervention: | Other: Data collection post infusion | |||||
10 | Recruiting | New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis | ||||
Condition: | Reactive Arthritis | |||||
Interventions: | Drug: interferon-gamma; Drug: infliximab; Drug: dmard | |||||
11 | Not yet recruiting | Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis | ||||
Condition: | Arthritis, Juvenile Rheumatoid | |||||
Intervention: | Drug: Sulfasalazine | |||||
12 | Recruiting | Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis | ||||
Condition: | Arthritis, Juvenile Rheumatoid | |||||
Intervention: | Biological: Measles, Mumps, Rubella vaccination | |||||
13 | Not yet recruiting | Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis | ||||
Condition: | Arthritis, Juvenile Rheumatoid | |||||
Interventions: | Drug: Celecoxib; Drug: nsNSAIDs | |||||
14 | Recruiting | Yoga for Arthritis | ||||
Conditions: | Rheumatoid Arthritis; Osteoarthritis | |||||
Intervention: | Behavioral: yoga | |||||
15 | Recruiting | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | ||||
Condition: | Arthritis, Rheumatoid | |||||
Interventions: | Drug: Adalimumab; Drug: Placebo | |||||
16 | Recruiting | Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to MTX Therapy | ||||
Conditions: | Arthritis, Rheumatoid; Rheumatoid Arthritis | |||||
Interventions: | Drug: Ofatumumab; Drug: Placebo | |||||
17 | Recruiting | Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy | ||||
Conditions: | Arthritis, Rheumatoid; Rheumatoid Arthritis | |||||
Interventions: | Drug: Ofatumumab; Drug: Placebo | |||||
18 | Not yet recruiting | Remission Induction in Very Early Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: Etanercept, methotrexate and depomedrone; Drug: depemedrone | |||||
19 | Recruiting | Rituxan With or Without Methotrexate in Psoriatic Arthritis | ||||
Condition: | Psoriatic Arthritis | |||||
Intervention: | Drug: Rituximab | |||||
20 | Recruiting | Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: MR tablet formulation of prednisone; Drug: Placebo | |||||
21 | Recruiting | A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis | ||||
Condition: | Juvenile Idiopathic Arthritis | |||||
Interventions: | Drug: tocilizumab; Drug: Placebo; Drug: NSAIDs + methotrexate | |||||
22 | Recruiting | Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis | ||||
Condition: | Arthritis, Rheumatoid | |||||
Interventions: | Drug: Etanercept; Drug: Methotrexate | |||||
23 | Recruiting | Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Biological: MDX-1342; Biological: MDX-1342 Placebo | |||||
24 | Not yet recruiting | A Study to Assess CH-1504 in Patients With Active Rheumatoid Arthritis | ||||
Condition: | Arthritis, Rheumatoid | |||||
Interventions: | Drug: CH-1504; Drug: Methotrexate | |||||
25 | Recruiting | Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: Liquid Certolizumab pegol; Drug: Liquid Certolizumab pegol; Drug: Placebo; Drug: Placebo | |||||
26 | Recruiting | Health Outcomes in Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | ||||||
27 | Recruiting | Physical Activity Management for Clients With Arthritis | ||||
Conditions: | Osteoarthritis, Knee; Rheumatoid Arthritis | |||||
Intervention: | Behavioral: Lifestyle Physical Activity Management | |||||
28 | Recruiting | Clinically Important Changes in Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | ||||||
29 | Recruiting | Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Behavioral: Cognitive Behavioral Therapy; Behavioral: Tai Chi Chih; Behavioral: Health Education Seminar | |||||
30 | Recruiting | Quality of Sleep in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: diazepam, melatonin | |||||
31 | Recruiting | Curcumin in Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: curcumin | |||||
32 | Recruiting | Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA) | ||||
Conditions: | Active Systemic; Onset Juvenile Idiopathic Arthritis | |||||
Intervention: | Drug: ITF2357 | |||||
33 | Recruiting | Pharmacogenomics of Anti-TNF (Anti-Tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | ||||||
34 | Recruiting | Phase II Study With CC-10004 in Psoriatic Arthritis | ||||
Condition: | Psoriatic Arthritis | |||||
Intervention: | Drug: CC-10004 | |||||
35 | Recruiting | Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset(EPA) | ||||
Conditions: | Rheumatoid Arthritis; Early Inflammatory Arthritis | |||||
Intervention: | ||||||
36 | Not yet recruiting | Evaluation of Walk With Ease in Arthritis | ||||
Condition: | Arthritis | |||||
Interventions: | Behavioral: Walk with Ease - Group; Behavioral: Walk with Ease - Self; Behavioral: Control | |||||
37 | Recruiting | Study of Arthritis and Related Conditions | ||||
Conditions: | Arthritis; Synovitis | |||||
Intervention: | ||||||
38 | Recruiting | Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis | ||||
Condition: | Psoriatic Arthritis | |||||
Interventions: | Drug: Infliximab; Drug: Etanercept | |||||
39 | Recruiting | Long-Term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: ACZ885 | |||||
40 | Recruiting | Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: ACZ885; Drug: ACZ885; Drug: ACZ885; Drug: ACZ885 | |||||
41 | Recruiting | Rituximab in Rheumatoid Arthritis Lung Disease | ||||
Conditions: | Rheumatoid Arthritis; Interstitial Pneumonia | |||||
Intervention: | Drug: Rituximab | |||||
42 | Not yet recruiting | Inflammation and Insulin Resistance in Rheumatoid Arthritis (RA) | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: 1st Pioglitazone 45 mg PO once a day for 8 weeks, then Placebo; Drug: Placebo 1st then Pioglitazone | |||||
43 | Recruiting | Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: methotrexate; Drug: methotrexate | |||||
44 | Recruiting | An Safety and Efficacy Study of Golimumab(CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: CNTO148; Golimumab | |||||
45 | Recruiting | A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: AZD5672; Drug: Etanercept; Drug: Placebo; Drug: AZD5672; Drug: AZD5672; Drug: AZD5672 | |||||
46 | Recruiting | Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: Certolizumab pegol; Other: Placebo | |||||
47 | Recruiting | Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: HE3286; Drug: HE3286; Drug: HE3286 | |||||
48 | Recruiting | Study Evaluating 2 Dosing Regimens of TRU-015 in Rheumatoid Arthritis | ||||
Condition: | Active Rheumatoid Arthritis | |||||
Interventions: | Drug: TRU-015; Other: Placebo | |||||
49 | Recruiting | Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: ASK8007; Drug: Placebo | |||||
50 | Recruiting | Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis | ||||
Condition: | Arthritis, Rheumatoid | |||||
Interventions: | Drug: Etanercept; Drug: Methotrexate | |||||
Studies Shown (1-50) | Next (51-100) |